简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-08-18 13:09 Biocytogen’s Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth
2023-08-18 08:48 RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
2023-08-14 13:12 CAS and Molecule.one Announce a Strategic Collaboration to Accelerate Drug Discovery
2023-08-11 22:52 KBI Biopharma, Inc. Continues to Strengthen Leadership and Expertise With Key Executive Appointments
2023-08-10 08:46 Now Health International Celebrates Another Service Success
2023-08-09 09:16 Graminex® Rye Pollen Achieves Novel Food Registration in China and Appoints Guangzhou Narnia Biotechnology as Their Authorized Distribution Partner
2023-08-07 09:12 Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.
2023-08-04 20:58 Energy Vault Announces Commencement of Commissioning of World’s First EVx™ Gravity Energy Storage System
2023-08-03 19:50 Corebridge Financial to Sell Laya Healthcare to AXA
2023-08-03 15:28 The World Health Organization Includes the Cardiovascular Polypill Developed by the Spanish National Centre for Cardiovascular Research and Ferrer in its List of Essential Medicines
2023-08-03 11:12 ABEC Introduces 5 Year Warranty for CSR® Single-Use Systems Products
2023-08-01 15:22 First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
2023-07-31 11:30 Takeda Reports Strong First Quarter FY2023 Results, Driven by Growth & Launch Products
2023-07-28 16:04 Mouser Electronics Shares the Revolutionary Power of Digital Therapeutics in Latest Empowering Innovation Together Series
2023-07-28 09:02 Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications
2023-07-27 13:32 Galderma Achieves Record 2 B USD Net Sales for a Six-Month Period in H1 2023, as It Continues to Demonstrate Leading Execution and Innovation Capabilities in Dermatology
2023-07-27 13:25 The New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1
2023-07-27 10:26 AmbioPharm, a Global Peptide CDMO
2023-07-26 11:32 BaroPace Receives Approval for First-in-Human Clinical Trial
2023-07-25 21:44 Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

Business Wire Weibo

Press Releases

Latest Releases